Metamason, a healthcare-focused 3D printing company, has raised $3 million in seed funding to further develop Respere, a 3D-printed CPAP mask.
Metamason, a healthcare-focused 3D scanning and 3D printing company has raised $3M in seed funding led by 3P Equity Partners, a manufacturing-focused private equity firm located in San Jose, CA; and Tsing Capital, known as China’s foremost cleantech venture capital firm. The round also included a collection of individual angel investors throughout the country.
Metamason plans to use the funding to complete FDA regulatory clearance and run initial clinical trials for its patent-pending flagship product, Respere—a custom fit, 3D-printed CPAP mask designed for obstructive sleep apnea.
The company’s proprietary Scan-Fit-Print process uses 3D body scanning, patented algorithmic design, and on-demand 3D printing to create individually customized, ergonomic medical device products.
